Concise asymmetric synthesis of fully substituted isoxazoline-N-Oxide through lewis base catalyzed nitroalkene activation

Chemistry - A European Journal

Volumn 16, Issue 29, 2010, Pages 8605-8609

  Zhong, Cheng ^a   Gautam, Lekh Nath S ^a   Petersen, Jeffrey L ^a   Akhmedov, Novruz G ^a   Shi, Xiaodong ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Asymmetric synthesis; Clausenamide; Enantioselectivity; Isoxazoline N oxides; Lewis bases

Indexed keywords

ASYMMETRIC SYNTHESIS; GRAM-SCALE SYNTHESIS; INTERMOLECULAR CONDENSATION; ISOXAZOLINES; LEWIS BASE; LEWIS BASIS; N-OXIDES; SECONDARY AMINES; SULFUR YLIDES;

ALDEHYDES; ENANTIOSELECTIVITY; OXIDES; STEREOCHEMISTRY; SULFUR;

ELECTRON TRANSITIONS;

ALKENE; AMINE OXIDE; ISOXAZOLE DERIVATIVE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

ALKENES; CATALYSIS; CYCLIC N-OXIDES; ISOXAZOLES; MOLECULAR STRUCTURE;

EID: 77955124333     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.201001237     Document Type: Article

References (65)

1. For selected recent reviews, see: a) S. Perreault, T. Rovis. Chem. Soc. Rev. 2009, 38, 3149-3159;
2. b) C. A. Carson, M. A. Kerr, Chem. Soc. Rev. 2009. 38, 3051-3060;
3. c) V. Polshettiwar. R. S. Varma. Curr. Opin. Drug Discovery Dev. 2007. 10, 723-737;
4. d) D. M. D'Souza. T.J.J. Muller. Chem. Soc. Rev. 2007. 36. 1095-1108:
5. e) P. A. Tempest, Curr. Opin. Drug Discovery Dev. 2005, 8, 776-788.
6. For selected reviews, see: a) M. O. F. Khan, H.J. Lee, Chem. Rev. 2008, 108, 5131-5145;
7. b) T. Pinho e Melo, Curr. Org. Chem. 2005, 9, 925-958;
8. c) A. P. Kozikowski. Acc. Chem. Res. 1984, 17, 410-416.
9. For selected recent examples, see: a) V. Varshney, N.N. Mishra. P. K. Shukla, D. P. Sahu, Bioorg. Med. Chem. Lett. 2009, 19, 3573-3576:
10. b) P. P. Shao. F. Ye, A. E. Weber, X. H. Li, K. A. Lyons. W. H. Parsons, M. L. Garcia, B. T. Priest. M. M. Smith, J. P. Felix. B. S. Williams, G. J. Kaczorowski, E. McGowan, C. Abbadie, W. J. Martin. D. R. McMasters. Y. D. Oao, Bioorg. Med. Chem. Lett. 2009. 19, 5329-5333;
11. c) J. Kaffy, R. Pontikis. D. Carrez, A. Croisy, C. Monneret, J. C. Florent, Bioorg. Med. Chem. 2006, 14, 4067-4077:
12. d) Z. Mincheva. M. Courtois, J. Creche, M. Rideau. M. C. Viaud-Massuard, Bioorg. Med. Chem. 2004, 12, 191-197;
13. e) A. P. Kozikowski, K. Sato, A. Basu, J. S. Lazo, J. Am. Chem. Soc. 1989, 111, 6228-6234.
14. For selected recent example, see: a) K. Karthikeyan, T. V. Seelan. K. G. Lalitha. P. T. Perumal, Bioorg. Med. Chem. Lett. 2009, 19, 3370-3373;
15. b) M. Benltifa. J. M. Hayes. S. Vidal. D. Gueyrard, P. O. Goekjian, J. P. Praly. G. Kizilis. C. Tiraidis. K. M. Alexacou, E. D. Chrysina. S. E. Zographos. D. D. Leonidas. G. Archontis, N. G. Oikonomakos, Bioorg. Med. Chem. 2009, 17, 7368-7380:
16. c) R. Maurya, P. Gupta, G. Ahmad. D. K. Yadav, K. Chand, A. B. Singh. A. K. Tamrakar, A. K. Srivastava, Med. Chem. Res. 2008. 17, 123-136:
17. d) M. C Pirrung, L. N. Tumey, C. R. H. Raetz, J. E. Jackman. K. Snehalatha, A. L. McClerren, C. A. Fierke, S. L. Gantt, K. M. Rusche. J. Med. Chem. 2002, 45, 4359-4370.
18. For selected examples: a) A. L. Smith, E. N. Pitsinos, C. K. Hwang. Y. Mizuno, H. Saimoto, G. R. Scarlalo. T. Suzuki, K. C. Nicolaou, J. Am. Chem. Soc. 1993, 115, 7612-7624;
19. b) B. M. Trost, L. Li. S.D. Guile. J. Am. Chem. Soc. 1992. 114, 8745-8747.
20. For selected reviews: a) R. Y. Baiazitov, S. Nguyen, S. E. Denmark. Heterocycles 2008, 76. 143-154;
21. b) H. M. I. Osborn. N. Gemmell, L. M. Harwood, J. Chem. Soc. Perkin Trans. 1 2002, 2419-2438;
22. c) S. E. Denmark, D.S. Middlelon, J. Org. Chem. 1998, 63. 1604-1618.
23. For selected samples: a) R. A. Kunelsky, A.D. Dilman, S. L. Ioffe, M. I. Struchkova, Y. A. Strelenko, V. A. Tartakovsky, Org. Lett. 2003, 5, 4907-4909;
24. b) N. Scardovi, A. Casalini, P. Francesca, P. Righi, Org. Lett. 2002. 4, 965-968:
25. c) C. Galli. E. Marotta, P. Righi. G. Rosini, J. Org. Chem. 1995, 60, 6624-6626.
26. For selected examples of nitro compound [3 + 2] reactions: a) S. E. Denmark, M. Seierstad, B. Herbert. J. Org. Chem. 1999, 64. 884-901;
27. b) A. Voituriez, J. Moulinas. C. Kouklovsky, Y. Langlois, Synthesis 2003, 1419-1426;
28. c) P. Y. Roger, A. C. Durand, J. Rodriguez. J. P. Dulcere. Org. Lett. 2004, 6. 2027-2029;
29. d) A. Arrieta, D. Otaegui, A. Zubia, F. P. Cossio, A. Diaz-Ortiz, A. de La Hoz, M. A. Herrero. P. Prieto, C. Foces-Foces, J. L. Pizarro, M. I. Arriortua. J. Org. Chem. 2007, 72, 4313-4322
30. : C Foces-Foces, J. L. Pizarro, M. I. Arriortua, J. Org. Chem. 2007, 72, 4313-4322.
31. K. S. Huang, E. H. Lee, M. M. Olmstead, M. J. Kurth, J. Org. Chem. 2000, 65, 499-503.
32. a) C.-Y. Zhu, X.-M. Deng, X.-L. Sun, J.-C. Zheng. Y. Tang. Chem. Commun. 2008. 738-740;
33. b) C.-Y. Zhu. X.-M. Sun, X.-M. Deng. J.C. Zheng, Y. Tang. Tetrahedron 2008. 64. 5583-5589.
34. H. Jiang, P. Eisner, K. L. Jensen. A. Falcicchio, V. Marcos. K. A. Jørgensen, Angew. Chem. 2009, 121, 6976-6980;
35. Angew. Chem. Int. Ed. 2009, 48, 6844-6848.
36. a) X. Sun, S. Sengupta, J. L. Petersen, H, Wang, J. P. Lewis, X. Shi, Org. Lett. 2007, 9, 4495-4498;
37. b) C. Zhong, Y. Chen, J. L. Petersen, N. Akhmedov, X. Shi, Angew. Chem. 2009, 121, 1305-1308;
38. Angew. Chem. Int. Ed. 2009, 48, 1279-1282;
39. c) S. Sengupta, H. Duan, W. Lu, J. L. Petersen, X. Shi, Org. Lett. 2008, 10, 1493-1494;
40. d) Y. Chen, Y. Liu, J. L. Petersen, X. Shi, Chem. Commun. 2008, 3254-3256;
41. e) Y. Liu, W. Yan, Y. Chen, J. L. Petersen, X. Shi, Org. Lett. 2008, 10, 5389-5392;
42. f) H. Duan, W. Yan, S. Sengupta, X. Shi, Bioorg. Med. Chem. Lett. 2009, 19, 3899-3902.
43. a) Y. Chen, C. Zhong, X, Sun, N. Akhmedov, J. L. Petersen, X. Shi, Org. Lett. 2009, 11, 2333-2336;
44. b) Y. Chen, C. Zhong, X. Sun, N. Akhmedov, J. L. Petersen, X. Shi, Chem. Commun. 2009, 51, 50-5152;
45. c) C. Zhong, T. Liao, O. Tuguldur, X. Shi, Org. Lett. 2010, 12, 2064-2067.
46. H. Duan, X. Sun, W. Liao, J. L. Petersen, X. Shi, Org. Lett. 2008, 10, 4113-4116.
47. See the Supporting Information for the detailed screening conditions.
48. The detailed mechanistic study of the interaction between chiral secondary amine Lewis base and the nitro alkene or the intermediate is currently under investigation.
49. For recent successful selective addition of sulfur ylides to mono-substituted nitroalkenes, see: L.-Q. Lu, Y-J. Cao, X.-P. Liu, J. An, C.-J. Yao, Z.-H. Ming, W.-J. Xiao, J. Am. Chem. Soc. 2008, 130, 6946-6948.
50. For the synthesis of chiral sulfur ylides, see: a) J.-C. Zheng, C.-Y. Zhu, X.-L. Sun, Y. Tang, L.-X. Dai, J. Org. Chem. 2008, 73, 6909-6912;
51. for related studies in asymmetric chiral sulfur ylide auxiliaries, see: b) X.-L. Sun, Y. Tang, Acc. Chem Res. 2008, 41, 937-948;
52. c) Q.-G. Wang, X.-M. Deng, B.-H. Zhu, L.-W. Ye, X.-L. Sun, C.-Y. Li, C.-Y. Zhu, Q. Shen, Y. Tang, J. Am. Chem. Soc. 2008, 130, 5408-5409;
53. d) X.-M. Deng, P. Cai, S. Ye, X.-L. Sun, W-W. Liao, K. Li, Y. Tang, Y.-D. Wu, L-X. Dai, J. Am Chem Soc. 2006, 128, 9730-9740;
54. e) S. Ye, Z.-Z. Huang, C.-A. Xia, Y. Tang, L.-X. Dai, J. Am. Chem. Soc. 2002, 124, 2432-2433.
55. The single-crystal X-ray structure of 6a revealed the formation of a hydrogen bond for improved stereochemistry control. (Figure Presented)
56. a) E. Borredon, M. Delmas, A. Gaset, Tetrahedron 1987, 43, 3945-3954;
57. b) E. Borredon, F. Clavellinas, M. Delmas, A. Gaset, J. V. Sinisterrat, J. Org. Chem. 1990, 55, 501-504.
58. For further related studies, see: c) V. K. Aggarwal, J.N. Harvey, J. Richardson, J. Am. Chem. Soc. 2002, 124, 5747-5756;
59. d) V.K. Aggarwal, G. Hynd, W. Picoul, J. Vasse, J. Am Chem. Soc. 2002, 124, 9964-9965.
60. For the bioactivity of Clausenamide: a) X. Y. Wang, J. T. Zhang, J. Asian. Nat. Prod. Res. 2003, 5, 1-4;
61. b) X. Y. Wang, J. T. Zhang, Acta Pharmacol. Sin. 2001, 22, 1099-1102;
62. c) L. Xu, S.L. Liu, J. T. Zhang, Chirality 2005, 17, 239-244. For the synthesis of Clausenamide:
63. d) L. Yang, G. Deng, C.X. Wang, Z.T. Huang, J.P. Zhu, M. X. Wang, Org. lett. 2007, 9, 1387-1390;
64. e) T. Yakura, Y. Matsumura, M. Ikeda, Synlett 1991, 343-344.
65. 2D NMR studies and the X-ray structure for 8e are provided in the Supporting Information, and indicated the all-cis configuration of the γ-lectam.